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Abstract
Background: The therapeutic efficacy of human mesenchymal stem cells (hMSCs) for the treatment of hypoxic-
ischemic diseases is closely related to level of hypoxia in the damaged tissues. To elucidate the potential
therapeutic applications and limitations of hMSCs derived from human umbilical cords, the effects of hypoxia on
the morphology and proliferation of hMSCs were analyzed.
Results: After treatment with DFO and CoCl2, hMSCs were elongated, and adjacent cells were no longer in close
contact. In addition, vacuole-like structures were observed within the cytoplasm; the rough endoplasmic reticulum
expanded, and expanded ridges were observed in mitochondria. In addition, DFO and CoCl2 treatments for 48 h
significantly inhibited hMSCs proliferation in a concentration-dependent manner (P < 0.05). This treatment also
increased the number of cells in G0/G1 phase and decreased those in G2/S/M phase.
Conclusions: The hypoxia-mimetic agents, DFO and CoCl2, alter umbilical cord-derived hMSCs morphology and
inhibit their proliferation through influencing the cell cycle.
Background
Human mesenchymal stem cells (hMSCs) were first
identified by Friedenstein et al. [1] in 1974. As non-
hematopoetic, multipotent bone marrow stem cells,
hMSCs are more primitive and embryonic-like cells
with the potential to differentiate into lineage-com-
mitted progenitors and mature cells, such as osteoblasts
and fibroblasts [2]. However, bone marrow is not the
exclusive source of MSCs; they have been isolated from
virtually all post-natal and extra-embryonic tissues,
including amniotic membrane, placenta, umbilical cord,
and umbilical cord blood [3-5]. In recent years, hMSCs
have been commonly used in tissue engineering, cell
replacement therapy, gene therapy, and body organ/fluid
transplantation.
Oxygen is a potent signaling molecule, affecting the
fundamental characteristics of various types of cells.
Specifically, reduced oxygen levels or hypoxia influences
blood-brain barrier permeability through influencing
endothelial cell junctional complexes [6]. Furthermore,
hypoxia induced proliferation of hematopoietic bone
marrow stem cells [7]. In addition, hypoxia-inducible
factor-1 alpha (HIF-1a), a critical transcription factor in
the mammalian oxygen-sensing pathway, is activated in
response to hypoxia, altering tumor xenograft gene
expression, growth, and angiogenesis [8] possibly
through membrane type 1 metalloprotease [9]. MSCs
exposed to hypoxic conditions exhibit greater colony-
forming potential [10], faster and prolonged prolifera-
tion [11-13], and greater chemotaxis [9]. Exposure of
MSCs to hypoxia also prolonged their differentiation
[14].
Hypoxia is often induced by decreasing oxygen con-
centrations [15,16]. In addition, the hypoxia-mimetic
agents, cobalt chloride (CoCl2) and desferrioxamine
(DFO), an iron chelator, artificially induce hypoxia
through blocking the degradation of HIF-1a [17,18].
The effects of hypoxia-mimetic agents are comparable
to those resulting from reduced atmospheric oxygen
levels [17,19].
* Correspondence: liuhongwei0521@hotmail.com
† Contributed equally
5Department of Plastic Surgery and Cosmetology, the First Affiliated Hospital,
Jinan University, Guangzhou, 510630, China
Full list of author information is available at the end of the article
Zeng et al. BMC Cell Biology 2011, 12:32
http://www.biomedcentral.com/1471-2121/12/32
© 2011 Zeng et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.Analysis of stem cell proliferation and differentiation
is often carried out in 20% O2, which is much greater
than that found in vivo; arterial oxygen concentration is
approximately 12% while bone marrow ranges from 1 to
7% [20]. Therefore, the effects of DFO and CoCl2 on
human umbilical cord-isolated hMSCs were assessed.
The ultrastructure of hMSCs in response to hypoxia
was analyzed using atomic force microscopy (AFM) and
transmission electron microscopy (TEM). In addition,
the effects of hypoxia mimetics on hMSCs proliferation
were analyzed. Determining the effects of hypoxia on
hMSCs morphology and proliferation may contribute to
identifying the mechanisms by which hypoxia influences
hMSCs chemotaxis and migration as well as characterize
their therapeutic application for hypoxia-related disease.
Results
Morphological and immunophenotypic characterization
of umbilical cord-derived hMSCs
Both large and occasionally multi-nucleated hMSCs as
well as small, spindle-shaped mononucleated cells were
present in the primary hMSCs culture (Figure 1A). Fol-
lowing the second passage, the cultures were primarily
made up of the small, spindle-shaped cells, which con-
tinued to proliferate after numerous passages; the num-
ber of large hMSCs diminished (Figure 1B). Individual
spindle-shaped cells appeared after 3-4 days in culture,
while colonies formed as early as 5 days.
The primary hMSCs expressed CD44 (96.1%), CD29
(98.5%), and CD105 (98.6%) surface antigens whereas
expression of the CD106 (2.1%), CD40 (0.8%), CD34
(0.5%), CD45 (0.8%), and HLA-DR (0.7%) surface mole-
cules were below the detection limit (Figure 2A).
hMSCs differentiation
Following adipogenic induction, hMSCs morphology
changed from elongated, confluent fibroblastic-like cells
(Figure 3A) to oval-shaped cells; a distinct ring of red
coarse vacuoles around the cell periphery was observed
upon Oil Red O staining after the fourth day, becoming
larger and more numerous over time (Figure 3B). Upon
osteogenic differentiation, adherent monolayers of spin-
dle-shaped cells (Figure 3E) became multilayered cell
clusters surrounded by a matrix-like substance that was
visible after von Kossa staining (Figure 3F). In addition,
rapid mineralization and nodule formation characterized
by the accumulation of overcrowded fibroblast-like cells
in direct contact with one another was observed. The
cells bordering the nodules were fibroblastic, while
those near the centers were polygonal (Figure 3F).
Effects of DFO and CoCl2 on hMSCs proliferation
hMSCs proliferation rates were determined using the
MTT assay; logarithmic growth was observed after 48 h.
Decreased hMSCs proliferation was detected after DFO
(Figure 4A) and CoCl2 (Figure 4B) treatment. Specifi-
cally, significantly decreased cell growth was observed
after treatment with 120 μMD F Oa n d1 0a n d1 0 0μM
CoCl2 as compared to the untreated controls (all P <
0.05). After 48 h, the inhibition rates were 20.6, 25.2,
28.0, and 29.8% for cells treated with 15, 30, 60 and 120
μM DFO, respectively (P < 0.05). Similarly, the inhibi-
tion rates were 11.7, 14.2, 20.9, and 24.6% for hMSCs
treated for 48 h with 10, 25, 50, and 100 μMC o C l 2,
respectively (P < 0.05).
Effects of hypoxia mimetics on hMSCs cell cycle
As compared to the control group, the ratio of hMSCs
in the G0/G1 phase increased while those in the G2/M/
S phase decreased after DFO and CoCl2 treatment
(Table 1; Figure 2B). Although no significant differences
were observed among the various DFO or CoCl2 con-
centrations, an increasing trend was observed in the
number of cells in the G0/G1 phase while a decreasing
trend was detected in the number of cells in the G2/S/
M phase after treatment (Table 1; Figure 2B).
Effects of hypoxia mimetics on hMSCs morphology
After 72 h in normoxic conditions, AFM revealed
enlarged, spindle-shaped hMSCs up to 80 μmi nl e n g t h
and 30-40 μm wide (Figures 5A1, A2 and 5A2). In addi-
tion, a clear cytoskeleton, complex edge as well as
synapse-like structure, and fishtail-like or cicada wing-like
morphology were observed (Figures 5B1 and 5B2, enlarged
areas shown in 5C1 and 5C2). In addition, cells were in
close contact with each other and presented a reticular
structure, suggesting active cell-to-cell signaling (Figures
5D1 and 5D2, enlarged areas shown in 5E1 and 5E2).
hMSCs were exposed to factors inducing adipogenic
and osteogenic differentiation for 21 days in normoxic
conditions after which the morphology was assessed.
The nuclei of adipogenic-induced hMSCs moved to per-
ipheral area while the cell membranes became more
granular, which was suggestive of the S phase of the cell
cylce (Figures 3C and 3D). Osteogenic-induced hMSCs
Figure 1 Morphological changes in hMSCs primary cultures
over time. A) First passage at 5 days (100×). B) Third passage at 3
days (50×).
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entiated cells (Figures 3G and 3H).
Altered hMSCs morphology was observed after treat-
ment with DFO (Figures 6A1, A2 and 6A3) and CoCl2
(Figures 6B1, B2, and 6B3, enlarged areas of 6B1 and
6B2 shown in 6C1 and 6C2, respectively). Specifically,
the spindle-like cells elongated up to nearly 100 μm. In
addition, cell-to-cell contacts diminished, and gaps
appeared in between adjacent cells.
TEM analysis of control hMSCs revealed round cells
with surface protrusions and microvilli (Figure 7A). The
nuclei were irregularly shaped with ≥ one nucleoli, con-
taining a large amount of euchromatin and a smaller
amount of heterochromatin. With the exception of a
small amount of rough endoplasmic reticulum (Figures
7B and 7C), ribosomes, and mitochondria (Figure 7F)
with clear and continuous cristae, relatively few orga-
nelles were found in the cytoplasm, suggesting that they
had remained undifferentiated. After treatment with
DFO, more surface protrusions and microvilli, as well as
a large number of intracellular vacuole-like structures
were observed (Figures 7D and 7E). In addition, DFO
treatment resulted in shrinkage or partial disintegration
of the nuclear membrane, as well as chromatin conden-
sation. Furthermore, an expanded rough endoplasmic
reticulum, which was filled with a low density matrix,
Figure 2 Histograms representing the immunophenotype and cell cycle distribution as determined by flow cytometry. The phenotype
of hMSCs was determined after cell isolation (A). The cell cycle distribution was determined without (control) or with 120 μM DFO or with 100
μM CoCl2 for 48 h (B).
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mitochondria were not significantly different from the
control groups, mitochondria with an expanded ridge
and containing a high density matrix were observed in
DFO-treated hMSCs (Figure 7G). Significant changes in
other organelles were not observed.
Discussion
Human umbilical cords represent a promising source of
hMSCs, which can be conveniently isolated and induce
low immunogenicity. In addition, as compared to other
stem cell sources these present relatively few ethical issues.
The hMSCs isolated from umbilical cords were positive
for CD44, CD29 and CD105, and negative for CD106,
CD40, CD34, CD45 and HLA-DR surface antigens, con-
firming their identity as MSCs [21]. In addition, the iso-
lated hMSCs were able to differentiate into adipogenic
and osteogenic cells under specific culture conditions.
The intracellular cytoskeleton responds to external
mechanical stimuli [22]. Tapping mode AFM was used to
Figure 3 Adipogenic and osteogenic differentiation of hMSCs. Adipogenesis was detected by the formation of intracytoplasmic lipid
droplets stained with oil red O (A, no induction; B, induced cells; 100×). Osteogenic differentiation was demonstrated by calcium deposition as
evidenced von Kossa staining (E, no induction; F, induced cells; 100×). Atomic force microscopy of umbilical cord-derived hMSCs upon
adipogenic (C, D) and osteogenic (G, H) differentiation after 21 days in normoxic conditions were shown as error signal images (C,G) and 3-
dimension graphs (D,H).
Figure 4 Reduced hMSCs growth after treatment with hypoxia mimetics. A) hMSCs were treated with the indicated concentration of A)
DFO or B) CoCl2 at various time points. Data represent the mean ± SD. *P < 0.05 as compared to the control group.
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genic cell nuclei and their granular quality of the mem-
branes is suggestive of early S phase of the cell cycle.
Osteogenic-induced hMSCs appeared larger, squarer and
more rigid as compared to undifferentiated cells, which is
consistent with that reported by Danti et al. [23]. In addi-
tion, they were easily distinguishable from each other as
the differentiation process prevented their proliferation,
which also correlates with Danti et al [23].
Differentiation of MSCs is also influenced by hypoxia.
Qu et al. [24] reported that DFO increased the
osteoblastic differentiation of bone morphogenetic pro-
tein-2-treated MSCs. Valorani et al. [25] and Ren et al.
[ 1 2 ]o b s e r v e dt h a th y p o x i a( 2a n d8 % ,r e s p e c t i v e l y )
increased the adipogenic differentiation potential of
MSCs. These studies suggest that pre-culturing MSCs
under hypoxic conditions prior to transplantation may
enhance their efficacy.
As evidenced by clinical trials in hypoxic-ischemic dis-
eases, MSCs-based therapy has potential value in tissue
replacement and regeneration [26-28]. The effects of in
vivo oxygen concentrations, which are much lower than
Table 1 Effects of DFO and CoCl2 of different concentrations on cell cycle distribution of hMSCs detected by flow
cytometry with PI staining
DFO (μM) CoCl2 (μM)
Cell phases Control 15 120 25 100
G0/G1 (%) 80.03 ± 4.28 82.67 ± 3.25 86.41 ± 3.13 81.96 ± 2.21 85.87 ± 2.93
G2/M (%) 1.52 ± 0.57 1.35 ± 1.29 1.30 ± 1.32 1.37 ± 0.29 1.32 ± 0.74
S (%) 18.45 ± 4.10 15.98 ± 4.21 12.29 ± 1.95 16.67 ± 2.13 12.81 ± 2.87
(n = 3)
Figure 5 Atomic force microscopy of hMSCs under normoxic conditions. A typical long spindle, cytoskeleton (A1,A 2,A 3), and palpus-like or
cicada wing-like pseudopodium (B1,B2, enlarged areas shown in C1 and C2 respectively) were observed. The mesh-like cytoskeleton of adjacent
hMSCs (D1,D 2) can also been seen (enlarged areas shown in E1,E 2).
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gely unknown. Therefore, hMSCs proliferation and mor-
phology in response to hypoxia induced by DFO and
CoCl2 was assessed. After treatment with DFO and
CoCl2, hMSCs were more elongated, and gaps appeared
between adjacent cells. Thus, DFO and CoCl2 may inhi-
bit hMSCs growth by weakening cell-to-cell signaling.
The reduction in cell-cell junctions may also mediate
hMSCs migration induced by hypoxia (3% oxygen) [29].
Further studies are necessary to determine the effects of
DFO and CoCl2 treatment on the signaling pathways
that govern hMSCs migration.
The influence of hypoxia on hMSCs ultrastructure was
also explored by TEM. After treatment with DFO,
hMSCs contained a large number of unidentifiable
vacuoles that are early markers of apoptosis, which is
consistent with Ren et al. [12] using 8% oxygen. In addi-
tion, the observed shrinkage, disintegration, and dissolu-
tion of the nucleus, along with chromatin condensation
indicated early apoptosis. Consistent with the signs of
apoptosis, we found that hMSCs proliferation decreased
in a dose-dependent manner with increasing concentra-
tions of CoCl2 and DFO. However, discrepant effects of
physical hypoxia and hypoxia mimetics on MSCs prolif-
eration indicate differences. For example, Ren et al. [12]
reported that low oxygen levels (8%) promoted MSCs
proliferation, whereas DFO (120 μM) and CoCl2 (100
μM) inhibited their growth. Lavrentieva et al. [30]
reported that 1.5-5% oxygen levels increased the prolif-
erative capacity of hMSCs. Whereas Qu et al. [24] found
that DFO, ranging from 0 to 100 μM, inhibited cell
growth in a dose-dependent manner. HIF-1a levels may
differ under physically-induced hypoxia as opposed to
CoCl2-induced hypoxia [12,16] which may account for
these differences; however, further analysis is required.
The effects of CoCl2 and DFO on hMSCs proliferation
may be mediated by cell cycle changes. A larger percen-
tage of DFO- and CoCl2-treated cells in the G0/G1
Figure 6 Atomic force microscopy of hMSCs upon treatment with hypoxia mimetics. hMSCs were treated with 120 μMD F O( A 1,A 2,A 3)
and 100 μM CoCl2 (B1,B 2,B 3) for 4 days. Enlarged areas of B1 and B2 are shown in C1 and C2 respectively.
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M/S phase decreased. Similar results were reported by
Holzwarth et al. [31], who reported hMSCs accumula-
tion in the G1 phase at 1% oxygen. Further studies are
necessary to determine if the cell cycle effects of hypoxia
mimetics can be recapitulated under low oxygen
conditions.
There are several study limitations that warrant dis-
cussion. Firstly, the present study analyzed the effects of
hypoxia mimics on hMSCs; however, the effects of phy-
sical hypoxia were not assessed. Further studies will be
carried out to compare the effects of physical hypoxia
and hypoxia mimetics on hMSCs morphology and
growth. In addition, the effects of DFO and CoCl2 on
hMSC HIF-1a levels were not analyzed. However, pre-
vious studies using the same concentrations of DFO and
CoCl2 used in the present study have reported upregula-
tion of HIF-1a expression [12,32]. Furthermore, the pre-
sent study did not analyze the influence of DFO and
CoCl2 on MSCs differentiation. Although the effects of
these agents on MSCs morphology is suggestive of
greater self-renewal capacity as hMSCs broaden and
flatten with differentiation [33], and differentiation was
associated with changes in nuclear morphology [34,35],
determining their effects on MSCs differentiation will be
the focus of future studies. Finally, the effects of
hypoxia-induced morphological changes on MSCs func-
tion (e.g., cell migration, homing or immune regulatory
effect) was not explored in the present study, but will be
analyzed in future studies. Although the present study
has its limitations, determining the ways in which MSCs
respond to environments with lower than atmospheric
oxygen concentrations, such as the blood, bone marrow,
and cartilage, is crucial for their successful use regenera-
tive medicine. The present study advances our under-
standing of the influences of hypoxia on MSCs
morphology and proliferation.
Conclusions
We isolated and cultured hMSCs from umbilical cords.
The proliferation of hMSCs was inhibited by DFO and
CoCl2. The cell surface and ultrastructure was viewed
with atomic force microscopy and transmission electron
microscopy after DFO- and CoCl2-induced hypoxia,
Figure 7 Transmission electron microscopy of hMSCs. A) Complete view of untreated (8900×) or D and E) DFO-treated hMSCs after 3 days
(8900×). (B and C) The endoplasmic reticulum of untreated hMSCs (24000×). F) The mitochondria of untreated (30000×) and G) DFO-treated
hMSCs (30000×).
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data will provide a better understanding of the potential
therapeutic applications of hMSCs in hypoxic-ischemic
disease.
Methods
Isolation and culture of hMSCs from umbilical cord and
treatment with hypoxia-mimetic agents
hMSCs were obtained from the umbilical cords of
healthy full-term infants born by cesarean section. Tis-
sues were washed with phosphate buffered saline (PBS),
cut into approximately 1 cm
3 pieces, and digested with
0.2% type II collagenase (Gibco, USA) at 37°C for 5-6 h.
After filtration and centrifugation, the cells were incu-
bated in DMEM/F12 medium supplemented with 10%
fetal bovine serum (FBS, Gibco, USA), 100 U/mL peni-
cillin and 100 U/mL streptomycin. Cells were inoculated
at density of 1 × 10
6 cells/mL in 25 cm
2 culture flasks
(Corning, NY) and maintained at 37°C in a humidified
atmosphere containing 5% CO2. After 4-5 days, non-
adherent cells were removed. The culture medium was
replaced every 3 days, and adherent cells were cultured
until they reached 80-90% confluence. Cells at passage
3-7 were used to analyze the effects of hypoxia-mimetic
agents. Informed consent for the use of the umbilical
cords was obtained from each mother prior to surgery.
The study was approved by The Ethics Committee of
the First Affiliated Hospital, Jinan University, Guangz-
hou, China.
DFO and CoCl2 were dissolved in ultrapure water and
applied to the hMSCs cultures at concentrations of 10,
25, 50, and 100 μM for CoCl2 and 15, 30, 60, and 120
μM for DFO. Control groups consisted of cells grown in
the absence of DFO and CoCl2.
Immunophenotype determination and cell cycle analysis
hMSCs were incubated with either phycoerythrin or
FITC-conjugated antibodies specific for CD29, CD44,
CD90, CD105, CD106, CD40, CD34, and CD45 (BD
Biosciences, San Jose, CA). Mouse isotype control anti-
bodies served as negative controls. Cells were stained
with a single label and analyzed by flow cytometry using
a BD FACSCalibur.
Cell cycle was analyzed through propidium iodide
(PI)-staining. hMSCs (10
6 cells) in the third passage
were fixed, permeabilized in 70% cold ethanol at 4°C for
24 h, and treated with 200 μg/mL RNase A for 30 min
at 37°C. hMSCs were then incubated in 40 μg/mL PI for
5 min at room temperature, and placed on ice until ana-
lysis by flow cytometry.
Analysis of hMSCs differentiation
To evaluate hMSCs properties, adherent cells (in the
third passage, at 80-90% confluence) were subjected
to adipogenic and osteogenic differentiation in vitro,
according to established protocols [36,37]. For adipo-
genic differentiation, cells were incubated in DMEM/
F12 media supplemented with 10% FBS, 100 U/mL
penicillin, 100 U/mL streptomycin, 5 μg/mL insulin,
50 mM indomethacin, 1 μM dexamethasone, and 0.5
mM 3-isobutyl-1-methylxanthine. Adipogenic differ-
entiation was confirmed on the 21st day by observing
the intracellular accumulation of lipid-rich vacuoles
stained with oil red O. For osteogenic differentiation,
cells were incubated in DMEM/F12 media supple-
mented with 10% FBS, 100 U/mL penicillin, 100 U/
mL streptomycin, 10 mM b-glycerol phosphate, 100
nM dexamethasone, and 50 μM ascorbate 2-phos-
phate for 21 days. Osteogenic differentiation was
confirmed by the accumulation of mineralized cal-
cium phosphate and assessed using the von Kossa
staining method, which entails incubating the cells in
1% silver nitrate for 60 min under ultraviolet light
followed by 3% sodium thiosulfate for 5 min at room
temperature.
MTT proliferation assay
After treatment, cell growth media was replaced with
200 μLM T Ts o l u t i o n( 5g / Li nP B S )p e rw e l lf o r4h
after which it was replaced with 150 μL dimethyl sulph-
oxide. Quantification was then carried out using a
microplate reader at 570 nm; a 630 nm filter was used
as a reference.
Atomic force microscopy
hMSCs were cultured on glass coverslips in growth
media alone (control group) or containing 120 μM DFO
or 100 μMC o C l 2. After the cells reached 70-80% con-
fluence at 72 h, they were gently washed with PBS, fixed
with 4% paraformaldehyde, washed with demineralized
water, and air dried. Tapping-mode atomic force micro-
scopy analysis (Autoprobe CP research, Thermomicro-
scopes, California, USA) was performed with silicon
nitride tips (spring constant, 0.9 N/m) using a Park
Scientific Instruments commercial instrument (MPP-
31123). The scanning speed was 0.4-1HZ. The IP2.1
software (Thermomicroscopes Proscan Image Processing
Software Version 2.1, California, USA) applied smooth-
ing analysis to the resulting images.
Transmission electron microscopy
TEM was used to assess the morphological characteris-
tics of hMSCs. hMSCs cultured for 72 h in media con-
taining 120 μM DFO were immediately fixed at 4°C
with 2.5% glutaraldehyde, post-fixed in osmium, and
routinely processed for TEM assessment (PHILIP5 TEC-
NAI 10, HOLLAND). Cells cultured in complete med-
ium alone were used as a control group.
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Statistical analyses were performed using SPSS 15.0
s t a t i s t i c ss o f t w a r e( S P S SI n c ,C h i c a g o ,I L ,U S A ) .D a t a
were expressed as mean ± standard deviation (SD).
One-way ANOVA test with a post-hoc Bonferoni com-
parison was performed to compare the data among
concentrations. Furthermore, a repeated ANOVA test
for repeated cell growth was performed to compare
the data among concentrations. Finally, a generalized
linear model analysis was applied to show changes in
data over time. All P-values < 0.05 were considered
significant.
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